Outbreak Summary: A Fatal Voyage
In April 2026, the Dutchflagged polar expedition cruise ship MS Hondius departed from Ushuaia, Argentina. On 6 April, a passenger developed fever and headache, dying on board five days later. His wife also fell ill and died after being transferred to South Africa. Subsequently, a 69yearold British passenger tested positive for hantavirus and is in intensive care. As of 6 May, WHO reported eight cases (three confirmed, five suspected) and three deaths.|

What is Hantavirus and Why Has It Raised International Concern?
Hantaviruses are pathogens mainly carried by rodents. Humans become infected by inhaling aerosols from infected animal excreta. Initial symptoms are flulike, but the disease can rapidly lead to respiratory failure. As of May 2026, no licensed vaccine or specific antiviral treatment is available. In the Americas, hantavirus pulmonary syndrome (HPS) caused by hantavirus has a case fatality rate of 3840%. Globally, an estimated 150,000200,000 cases occur each year. The incubation period can be 18 weeks, complicating source tracing.
International Response and Latest Developments
Following the outbreak, multiple countries and international organisations responded swiftly:
-WHO coordination with affected countries. WHO has issued outbreak notifications under the International Health Regulations and is coordinating responses. Dr Van Kerkhove stated that WHO is working with Spanish authorities to facilitate the ship’s docking for epidemiological investigation and disinfection.
-Transfer of critically ill patients. South Africa confirmed a critically ill British male patient receiving isolated care in Johannesburg. The Dutch authorities are coordinating repatriation of two ill crew members and the bodies of the deceased via a sealed charter flight.
-Virus sequencing under way.Virus sequencing is under way and has now confirmed the strain responsible for the outbreak as the Andes virus, with genetic analysis of two patients already completed, according to WHO and local health officials.
Understanding the Andes Virus: A Rare Hantavirus Capable of Human-to-Human Transmission
Hantaviruses are typically contracted through environmental exposure—inhaling aerosols from the urine, droppings, or saliva of infected rodents. They are not generally known for person-to-person transmission. However, the strain identified in this outbreak is the Andes virus, the only species among more than 38 known hantavirus strains that has documented human-to-human transmission. Cruise ships, crowded, confined, and with limited medical facilities, are high-risk settings for diseases like Andes virus. Rapid and accurate identification of the infection type and transmission chain is therefore critical for outbreak control.
Why Precision Detection and Tracing Matters
Early detection and precise tracing rely on advanced molecular diagnostics and sequencing. WHO noted that the two confirmed cases were diagnosed by PCR. Distinguishing environmental exposure, closecontact transmission, or preboarding infection requires higherresolution techniques. Wholegenome sequencing is essential to determine the virus’s origin and any genetic changes.
Macro & MicroTest: Technical Support for Hantavirus Outbreak Response
Macro & MicroTest offers a complete “screening – typing – sequencing & tracing” solution for hantavirus.
Nucleic acid detection: Realtime PCR kits with sensitivity down to 500 copies/mL, providing universal screening of Hanta Virus (Andes type covered). Compatible with ABI 7500, BioRad CFX, and other mainstream instruments.
Wholegenome sequencing and tracing: Probecapture enrichment kits (Illumina and MGI versions, including an automated library prep. version), safely and efficiently capture the full hantavirus genome.

The company has collaborated with Chinese scientists to characterise viruses from rodents and shrews (hantavirus included), supporting virus tracing, mutation monitoring, and transmission chain reconstruction.
The May 2026 MS Hondius outbreak is a notable global event. While the overall public health risk remains low according to WHO, the confirmed human-to-human transmission of this particular strain and the challenges of outbreak control in closed environments warrant close attention. From rapid PCR testing to whole-genome sequencing, precise diagnostic and tracing technologies are essential. Macro & Micro-Test remains committed to providing these solutions for infectious pathogens including zoonotic viruses, contributing to global public health security.
Related Kits
Post time: May-07-2026
